MedTest Dx FDA-approved quantitative test for G6PD
May 2020—MedTest Dx announced the availability of its Pointe Scientific–branded assay for the highly sensitive quantification of G6PD in whole blood.
Webinars and Sponsored Roundtables — Register Now
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
MedTest Dx
MedTest Dx FDA-approved quantitative test for G6PD
April 20, 2020—MedTest Dx announced the availability of its Pointe Scientific–branded assay for the highly sensitive quantification of G6PD in whole blood.
MedTest Dx releases new line of calibrators, controls
September 2019—MedTest Dx introduced at the 2019 American Association for Clinical Chemistry annual scientific meeting an improved line of Clinitox Calibrators and Controls for confirmation testing. The product line aims to provide laboratories performing drugs of abuse testing a comprehensive and reliable calibration and controls solution with extended shelf life and simplified documentation.
MedTest chem assays, hematology analyzer
Aug. 2, 2018—MedTest Dx introduced its BA-800M Clinical Analyzer for general chemistry with a full line of reagents and launched its BC-5390 5-Part Differential Hematology Analyzer at the 2018 American Association for Clinical Chemistry Annual Scientific Meeting, in Chicago. The MedTest Dx BA-800M is a fully automated, discrete random-access chemistry analyzer designed for mid- to large-volume clinical testing laboratories now available with reagents manufactured in the U.S. in a GMP-regulated and ISO 13485-certified environment. The BA-800M has a throughput of
Urine drug tests for forensic use, 2/18
February 2018—MedTest announced the commercial availability of four forensic use only urine drug tests for use on its BS-200, BS-480, and BA-800M chemistry analyzers. The four new assays are DRI Fentanyl, Cedia AB-PINACA (spice K2), Cedia UR-144/XLR-11 (spice K2), and DRI Ethyl Glucuronide.
Full chemistry menu for BioLis 24i instrument, 9/17
September 2017—MedTest’s Pointe Scientific product brand has developed a full line of chemistry reagents that are manufactured and packaged in barcoded reagent containers for use on the BioLis 24i chemistry analyzer, also known as the CLC480 or MGC 240 chemistry analyzer.
Drugs of abuse screening reagents, 6/17
June 2017—MedTest announced the commercial launch of urine drugs of abuse screening reagents on the Mindray BA-800M chemistry analyzer for use in clinical laboratories in the United States.
Drugs of abuse screening reagents, 4/17
April 2017—MedTest announced the commercial launch of urine drugs of abuse screening reagents on the Mindray BA-800M chemistry analyzer for use in clinical laboratories in the United States.
Hematology analyzer cleared, 11/16
November 2016—Mindray has received 510(k) clearance from the Food and Drug Administration to market and sell the Mindray BC-5390 Auto Hematology Analyzer. The Mindray BC-5390 analyzer is designed to meet the testing needs of mid-volume hematology laboratories while offering features commonly found on large-volume analyzers.
25-OH vitamin D assay, 6/16
June 2016—MedTest announced the availability of a 25-OH Vitamin D Assay for the BS-480 chemistry analyzer. MedTest is the exclusive U.S. distributor of the BS-480 analyzer including manufacturing and distribution of reagents, calibrators, and quality control products for the general chemistry and drugs of abuse testing markets in the United States and Canada.